Mater Research
Support Us
Home   Clinical Trials
Back

Medicinal cannabis for palliative care patients - exploring detection of cannabis in saliva, urine and blood tests.

Advanced Cancer

This study explores the detection of cannabis in saliva, urine and blood tests in advanced cancer patients taking CBD-dominant medicinal cannabis products. Patients will take a cannabis product that mostly contains CBD with small amounts of THC (the ingredient responsible for intoxication). Saliva, urine and blood will be regularly tested for THC to determine how strongly it is detected and for how long tests remain positive after patients stop taking the medication.

Category
Trial Status
Recruiting
Trial Phase
Phase 4 Drug Trial
Trial contact details
Contact Person
Mater Palliative and Supportive Care Research
Email
Phone
What you need to know

Who can take part?

  • People over 18 years old with advanced cancer
  • People receiving standard palliative care
  • People who are willing to not drive for the entirety of the trial
  • People who test negative for THC at the beginning of the trial and agree not to use any other cannabis products until the trial is complete
  • People without a history of psychiatric or substance use disorders
  • People without severe liver or kidney impairment
  • People who are not pregnant and who agree to avoid pregnancy until at least 12 weeks after the trial

What is involved for you?

  • Taking study medication for 4 weeks
  • Face-to-face visits each week
  • Regular phone calls with research nurses
  • Giving blood and urine samples
  • Testing saliva at home with provided kits
  • Medical assessments and questionnaires

Trial dates

This trial is accepting participants until December 2024.

Back

All research clinical trials news

2023 was an outstanding year for Mater Research with $13.7 million in grant funding received and 424 publications recorded.

29

Feb

Highlighting Mater Research’s year of achievements: 2023 Annual Report

When Monique Perry was diagnosed with aggressive triple-negative breast cancer she feared her family history was about to repeat itself.

27

Oct

Clinical trials give Queensland breast cancer patients hope

Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.

23

May

Mater launches trial of Australian-first flu vaccine

Displaying results 1-3 (of 18)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >| 

TrIAl Categories

IN THIS SECTION

Skip Navigation Links.